Related references
Note: Only part of the references are listed.Mechanisms of C-peptide-mediated rescue of low O2-induced ATP release from erythrocytes of humans with Type 2 diabetes
Jennifer P. Richards et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2015)
Low O2-induced ATP release from erythrocytes of humans with type 2 diabetes is restored by physiological ratios of C-peptide and insulin
Jennifer P. Richards et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2014)
3D-printed fluidic devices enable quantitative evaluation of blood components in modified storage solutions for use in transfusion medicine
Chengpeng Chen et al.
ANALYST (2014)
Evaluation of 3D Printing and Its Potential Impact on Biotechnology and the Chemical Sciences
Bethany C. Gross et al.
ANALYTICAL CHEMISTRY (2014)
COMBINED ZINC SUPPLEMENTATION WITH PROINSULIN C-PEPTIDE TREATMENT DECREASES THE INFLAMMATORY RESPONSE AND MORTALITY IN MURINE POLYMICROBIAL SEPSIS
Siarhei Slinko et al.
SHOCK (2014)
Synergistic effects of C-peptide and insulin on low O2-induced ATP release from human erythrocytes
Jennifer P. Richards et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2013)
Microfabrication of human organs-on-chips
Dongeun Huh et al.
NATURE PROTOCOLS (2013)
The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes
John Wahren et al.
DIABETES (2012)
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants
Goodarz Danaei et al.
LANCET (2011)
C-PEPTIDE AMELIORATES KIDNEY INJURY FOLLOWING HEMORRHAGIC SHOCK
Ranjit S. Chima et al.
SHOCK (2011)
Albumin as Fatty Acid Transporter
Ger J. van der Vusse
DRUG METABOLISM AND PHARMACOKINETICS (2009)
Zinc-activated C-peptide resistance to the type 2 diabetic erythrocyte is associated with hyperglycemia-induced phosphatidylserine externalization and reversed by metformin
Jennifer A. Meyer et al.
MOLECULAR BIOSYSTEMS (2009)
Interactions between multiple cell types in parallel microfluidic channels: Monitoring platelet adhesion to an endothelium in the presence of an anti-adhesion drug
Chia-Jui Ku et al.
ANALYTICAL CHEMISTRY (2008)
Is C-peptide replacement the missing link for successful treatment of neurological complications in type 1 diabetes?
Anders A. F. Sima et al.
CURRENT DRUG TARGETS (2008)
C-Peptide and Its C-Terminal Fragments Improve Erythrocyte Deformability in Type 1 Diabetes Patients
Thomas Hach et al.
EXPERIMENTAL DIABETES RESEARCH (2008)
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Felix Kratz
JOURNAL OF CONTROLLED RELEASE (2008)
Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter
J. A. Meyer et al.
DIABETOLOGIA (2008)
C-peptide is a bioactive peptide
J. Wahren et al.
DIABETOLOGIA (2007)
Addressing a vascular endothelium array with blood components using underlying microfluidic channels
Luiza I. Genes et al.
LAB ON A CHIP (2007)
C-peptide: a redundant relative of insulin?
L. Luzi et al.
DIABETOLOGIA (2007)
Separate functional features of proinsulin C-peptide
M Henriksson et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Effects of C-peptide on microvascular blood flow and blood hemorheology
T Forst et al.
EXPERIMENTAL DIABESITY RESEARCH (2004)
Selective chemical treatment of cellular microdomains using multiple laminar streams
S Takayama et al.
CHEMISTRY & BIOLOGY (2003)
C-peptide binding to human cell membranes:: Importance of Glu27
A Pramanik et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Combination therapies with insulin in type 2 diabetes
H Yki-Järvinen
DIABETES CARE (2001)
Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus
BL Johansson et al.
DIABETIC MEDICINE (2000)
Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I
T Forst et al.
CLINICAL SCIENCE (2000)
Share Paper
